Primary Site >> Biliary tract Cancer
Gene >> MET
| 1. | |||||||||||
| Journal: | Hepatology. 1999 May;29(5):1453-62. | ||||||||||
| Title: | Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma. | ||||||||||
| Author: | Radaeva, S|Ferreira-Gonzalez, A|Sirica, A E | ||||||||||
| PMID: | 10216129 | ||||||||||
| 2. | |||||||||||
| Journal: | In Vitro Cell Dev Biol Anim. 2001 Jan;37(1):17-25. | ||||||||||
| Title: | Characterization of a new rat cell line established from 2'AAF-induced combined hepatocellular cholangiocellular carcinoma. | ||||||||||
| Author: | Gil-Benso, R|Martinez-Lorente, A|Pellin-Perez, A|Navarro-Fos, S|Gregori-Romero, M A|Carda, C|Callaghan, R|Peydro-Olaya, A|Llombart-Bosch, A | ||||||||||
| PMID: | 11249201 | ||||||||||
| 3. | |||||||||||
| Journal: | J Gastroenterol Hepatol. 2001 Apr;16(4):363-72. | ||||||||||
| Title: | Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies. | ||||||||||
| Author: | Sirica, A E|Lai, G H|Zhang, Z | ||||||||||
| PMID: | 11357901 | ||||||||||
| 4. | |||||||||||
| Journal: | Oncol Rep. 2002 Jan-Feb;9(1):35-41. | ||||||||||
| Title: | C-met and hepatocyte growth factor expression in combined hepatocellular and cholangiocarcinoma. | ||||||||||
| Author: | Varnholt, Heike|Asayama, Yoshiki|Aishima, Shin-ichi|Taguchi, Ken-ichi|Sugimachi, Keishi|Tsuneyoshi, Masazumi | ||||||||||
| PMID: | 11748452 | ||||||||||
| 5. | |||||||||||
| Journal: | Histopathology. 2002 Mar;40(3):269-78. | ||||||||||
| Title: | c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma. | ||||||||||
| Author: | Aishima, S-I|Taguchi, K-I|Sugimachi, K|Shimada, M|Sugimachi, K|Tsuneyoshi, M | ||||||||||
| PMID: | 11895493 | ||||||||||
| 6. | |||||||||||
| Journal: | Hum Pathol. 2003 Dec;34(12):1337-44. | ||||||||||
| Title: | Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor. | ||||||||||
| Author: | Sasaki, Motoko|Tsuneyama, Koichi|Ishikawa, Akira|Nakanuma, Yasuni | ||||||||||
| PMID: | 14691921 | ||||||||||
| 7. | |||||||||||
| Journal: | Cancer Res Treat. 2005 Jun;37(3):171-6. | ||||||||||
| Title: | Co-expression of cox-2, C-met and beta-catenin in cells forming invasive front of gallbladder cancer. | ||||||||||
| Author: | Moon, Woo Sung|Park, Ho Sung|Lee, Ho|Pai, Rama|Tarnawski, Andrzej S|Kim, Kyung Ryoul|Jang, Kyu Yun | ||||||||||
| PMID: | 19956499 | ||||||||||
| 8. | |||||||||||
| Journal: | Cancer Res. 2006 Jul 1;66(13):6622-7. | ||||||||||
| Title: | Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice. | ||||||||||
| Author: | Farazi, Paraskevi A|Zeisberg, Michael|Glickman, Jonathan|Zhang, Yan|Kalluri, Raghu|DePinho, Ronald A | ||||||||||
| PMID: | 16818635 | ||||||||||
| 9. | |||||||||||
| Journal: | J Surg Res. 2006 Nov;136(1):78-84. Epub 2006 Sep 1. | ||||||||||
| Title: | Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met. | ||||||||||
| Author: | Leelawat, Kawin|Leelawat, Surang|Tepaksorn, Panada|Rattanasinganchan, Panthip|Leungchaweng, Anicha|Tohtong, Rutaiwan|Sobhon, Prasert | ||||||||||
| PMID: | 16950403 | ||||||||||
| 10. | |||||||||||
| Journal: | Korean J Gastroenterol. 2007 Dec;50(6):370-8. | ||||||||||
| Title: | [Expressions and clinical significances of c-met, c-erbB-2, COX-2, and IL-6 in the biliary tract cancers]. | ||||||||||
| Author: | Joo, Hyun Ho|Song, Eun Young|Jin, Sang Hwa|Oh, Sang Hoon|Choi, Young Kil | ||||||||||
| PMID: | 18159174 | ||||||||||
| 11. | |||||||||||
| Journal: | Cancer Res. 2008 Jan 15;68(2):553-60. | ||||||||||
| Title: | Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids. | ||||||||||
| Author: | Lim, Kyu|Han, Chang|Xu, Lihong|Isse, Kumiko|Demetris, Anthony J|Wu, Tong | ||||||||||
| PMID: | 18199552 | ||||||||||
| 12. | |||||||||||
| Journal: | World J Gastroenterol. 2008 May 21;14(19):2990-4. | ||||||||||
| Title: | c-Met targeted therapy of cholangiocarcinoma. | ||||||||||
| Author: | Socoteanu, Matei-P|Mott, Frank|Alpini, Gianfranco|Frankel, Arthur-E | ||||||||||
| PMID: | 18494048 | ||||||||||
| 13. | |||||||||||
| Journal: | Oncology. 2009;76(4):293-300. | ||||||||||
| Title: | A comprehensive analysis of immunohistochemical studies in intrahepatic cholangiocarcinoma using the survival tree model. | ||||||||||
| Author: | Iguchi, Tomohiro|Yamashita, Natsumi|Aishima, Shinichi|Kuroda, Yousuke|Terashi, Takahiro|Sugimachi, Keishi|Taguchi, Ken-ichi|Taketomi, Akinobu|Maehara, Yoshihiko|Tsuneyoshi, Masazumi | ||||||||||
| PMID: | 19262069 | ||||||||||
| 14. | |||||||||||
| Journal: | BMC Cancer. 2010 Jun 18;10:302. | ||||||||||
| Title: | Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines. | ||||||||||
| Author: | Xu, Ling|Hausmann, Martin|Dietmaier, Wolfgang|Kellermeier, Silvia|Pesch, Theresa|Stieber-Gunckel, Manuela|Lippert, Elisabeth|Klebl, Frank|Rogler, Gerhard | ||||||||||
| PMID: | 20565817 | ||||||||||
| 15. | |||||||||||
| Journal: | Cancer. 2010 Dec 1;116(23):5440-51. | ||||||||||
| Title: | Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients. | ||||||||||
| Author: | Huang, Xiao-Yong|Ke, Ai-Wu|Shi, Guo-Ming|Ding, Zhen-Bin|Devbhandari, Ranjan Prasad|Gu, Fang-Ming|Li, Quan-Lin|Dai, Zhi|Zhou, Jian|Fan, Jia | ||||||||||
| PMID: | 20715158 | ||||||||||
| 16. | |||||||||||
| Journal: | Am Surg. 2010 Apr;76(4):372-9. | ||||||||||
| Title: | Critical role of c-Met and Ki67 in progress of biliary carcinoma. | ||||||||||
| Author: | Sanada, Yuichi|Osada, Shinji|Tokuyama, Yasuharu|Tanaka, Yoshihiro|Takahashi, Takao|Yamaguchi, Kazuya|Yoshida, Kazuhiro | ||||||||||
| PMID: | 20420246 | ||||||||||
| 17. | |||||||||||
| Journal: | Br J Cancer. 2011 Jun 28;105(1):131-8. | ||||||||||
| Title: | Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma. | ||||||||||
| Author: | Miyamoto, M|Ojima, H|Iwasaki, M|Shimizu, H|Kokubu, A|Hiraoka, N|Kosuge, T|Yoshikawa, D|Kono, T|Furukawa, H|Shibata, T | ||||||||||
| PMID: | 21673683 | ||||||||||
| 18. | |||||||||||
| Journal: | Gastroenterology. 2012 Apr;142(4):1021-1031.e15. | ||||||||||
| Title: | Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. | ||||||||||
| Author: | Andersen, Jesper B|Spee, Bart|Blechacz, Boris R|Avital, Itzhak|Komuta, Mina|Barbour, Andrew|Conner, Elizabeth A|Gillen, Matthew C|Roskams, Tania|Roberts, Lewis R|Factor, Valentina M|Thorgeirsson, Snorri S | ||||||||||
| PMID: | 22178589 | ||||||||||
| 19. | |||||||||||
| Journal: | Cancer Sci. 2012 Jun;103(6):1165-71. | ||||||||||
| Title: | Significance of epithelial growth factor in the epithelial-mesenchymal transition of human gallbladder cancer cells. | ||||||||||
| Author: | Sasaki, Takamitsu|Kuniyasu, Hiroki|Luo, Yi|Kato, Daisuke|Shinya, Satoshi|Fujii, Kiyomu|Ohmori, Hitoshi|Yamashita, Yuichi | ||||||||||
| PMID: | 22404757 | ||||||||||
| 20. | |||||||||||
| Journal: | J Biol Chem. 2012 Nov 16;287(47):39812-23. | ||||||||||
| Title: | The tyrosine kinase c-Met contributes to the pro-tumorigenic function of the p38 kinase in human bile duct cholangiocarcinoma cells. | ||||||||||
| Author: | Dai, Rongyang|Li, Juanjuan|Fu, Jing|Chen, Yao|Wang, Ruoyu|Zhao, Xiaofang|Luo, Tao|Zhu, Junjie|Ren, Yibin|Cao, Jie|Qian, Youwen|Li, Ning|Wang, Hongyang | ||||||||||
| PMID: | 23024367 | ||||||||||
| 21. | |||||||||||
| Journal: | PLoS One. 2014 Dec 23;9(12):e115383. | ||||||||||
| Title: | Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. | ||||||||||
| Author: | Churi, Chaitanya R|Shroff, Rachna|Wang, Ying|Rashid, Asif|Kang, HyunSeon C|Weatherly, Jacqueline|Zuo, Mingxin|Zinner, Ralph|Hong, David|Meric-Bernstam, Funda|Janku, Filip|Crane, Christopher H|Mishra, Lopa|Vauthey, Jean-Nicholas|Wolff, Robert A|Mills, Gord | ||||||||||
| PMID: | 25536104 | ||||||||||
| 22. | |||||||||||
| Journal: | Technol Cancer Res Treat. 2016 Apr;15(2):227-33. | ||||||||||
| Title: | Prognostic Value of C-met Expression in Cholangiocarcinoma. | ||||||||||
| Author: | Mao, Zhi-Yuan|Zhu, Guang-Qing|Ren, Li|Guo, Xiao-Chuan|Su, Dan|Bai, Li | ||||||||||
| PMID: | 25873560 | ||||||||||
| 23. | |||||||||||
| Journal: | Sci Rep. 2016 May 3;6:25369. | ||||||||||
| Title: | Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer. | ||||||||||
| Author: | Chiang, Nai-Jung|Hsu, Chiun|Chen, Jen-Shi|Tsou, Hsiao-Hui|Shen, Ying-Ying|Chao, Yee|Chen, Ming-Huang|Yeh, Ta-Sen|Shan, Yan-Shen|Huang, Shiu-Feng|Chen, Li-Tzong | ||||||||||
| PMID: | 27136744 | ||||||||||
| 24. | |||||||||||
| Journal: | J Cancer. 2017 May 12;8(8):1395-1399. | ||||||||||
| Title: | The Clinical Impact of c-MET Over-Expression in Advanced Biliary Tract Cancer (BTC). | ||||||||||
| Author: | Heo, Mi Hwa|Kim, Hee Kyung|Lee, Hansang|Kim, Kyoung-Mee|Lee, Jeeyun|Park, Se Hoon|Park, Joon Oh|Lim, Ho Yeong|Kang, Won Ki|Park, Young Suk|Kim, Seung Tae | ||||||||||
| PMID: | 28638453 | ||||||||||
| 25. | |||||||||||
| Journal: | J Cancer Res Ther. 2018;14(Supplement):S28-S35. | ||||||||||
| Title: | Human epidermal growth factor receptor 2, epidermal growth factor receptor, and c-MET overexpression and survival in biliary tract cancer: A meta-analysis. | ||||||||||
| Author: | Zhou, Wei|Jiang, Congqing|Zhan, Nan|Lv, Xiaoguang|Fan, Lifang|Ninu, Maskey | ||||||||||
| PMID: | 29578146 | ||||||||||
| 26. | |||||||||||
| Journal: | Exp Ther Med. 2018 May;15(5):4543-4549. | ||||||||||
| Title: | PF-2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells. | ||||||||||
| Author: | Chen, Chen|Yang, Dinghua|Zeng, Qinghua|Luo, Liang|Cai, Chengzhi | ||||||||||
| PMID: | 29725387 | ||||||||||
| 27. | |||||||||||
| Journal: | Jpn J Clin Oncol. 2018 Aug 1;48(8):703-711. | ||||||||||
| Title: | New developments in systemic therapy for advanced biliary tract cancer. | ||||||||||
| Author: | Morizane, Chigusa|Ueno, Makoto|Ikeda, Masafumi|Okusaka, Takuji|Ishii, Hiroshi|Furuse, Junji | ||||||||||
| PMID: | 29893894 | ||||||||||
| 28. | |||||||||||
| Journal: | Int J Mol Sci. 2018 Oct 12;19(10). pii: ijms19103141. | ||||||||||
| Title: | MET Activation by a Macrocyclic Peptide Agonist that Couples to Biological Responses Differently from HGF in a Context-Dependent Manner. | ||||||||||
| Author: | Miao, Wenyu|Sakai, Katsuya|Imamura, Ryu|Ito, Kenichiro|Suga, Hiroaki|Sakuma, Tetsushi|Yamamoto, Takashi|Matsumoto, Kunio | ||||||||||
| PMID: | 30322054 | ||||||||||